Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
01/24/2023 | Codiak BioSciences, Inc. | CDAK | Grant | Stock Option (Right to Buy) | 465k | $0.74 | $344.1k | | 01/24/2023 |
01/20/2023 | Codiak BioSciences, Inc. | CDAK | Sale | Common Stock | 5.1k | $0.58 | $2.9k | | 01/19/2023 |
01/19/2023 | Codiak BioSciences, Inc. | CDAK | Exercise | Restricted Stock Units | 13.7k | $0.00 | $0 | | 01/19/2023 |
02/16/2022 | Codiak BioSciences, Inc. | CDAK | Grant | Stock Option (Right to Buy) | 61.2k | $5.21 | $319.1k | | 02/16/2022 |
02/16/2022 | Codiak BioSciences, Inc. | CDAK | Grant | Restricted Stock Units | 91.9k | $0.00 | $0 | | 02/16/2022 |
01/19/2022 | Codiak BioSciences, Inc. | CDAK | Grant | Stock Option (Right to Buy) | 200k | $7.21 | $1.4M | | 01/19/2022 |
01/19/2022 | Codiak BioSciences, Inc. | CDAK | Grant | Restricted Stock Units | 41k | $0.00 | $0 | | 01/19/2022 |
05/17/2021 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 1.8k | $3.67 | $6.4k | | 05/17/2021 |
01/22/2021 | Codiak BioSciences, Inc. | CDAK | Grant | Stock Option (Right to Buy) | 175k | $26.60 | $4.7M | | 01/22/2021 |
10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Common Stock | 9.6k | $0.00 | $0 | | 10/16/2020 |
10/16/2020 | Codiak BioSciences, Inc. | CDAK | Conversion | Series C Preferred Stock | 66k | $0.00 | $0 | | 10/16/2020 |
06/05/2020 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 13.2k | $5.29 | $70.1k | | 06/05/2020 |
11/13/2019 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (right to buy) | 7.4k | $2.43 | $18.1k | | 11/13/2019 |
06/10/2019 | Ovid Therapeutics Inc. | OVID | Grant | | 5.8k | $1.65 | $9.6k | | 06/10/2019 |
06/07/2019 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 5.8k | $1.60 | $9.3k | | 06/07/2019 |
04/01/2019 | IRONWOOD PHARMACEUTICALS INC | IRWD | Disposition | Class A Common Stock | 4.1k | $0.00 | $0 | | 04/01/2019 |
08/14/2018 | Ovid Therapeutics Inc. | OVID | Purchase | Common Stock | 5k | $6.49 | $32.4k | | 08/14/2018 |
06/07/2018 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 5.8k | $8.12 | $47.2k | | 06/07/2018 |
05/31/2018 | IRONWOOD PHARMACEUTICALS INC | IRWD | Grant | Class A Common Stock | 16.2k | $0.00 | $0 | | 05/31/2018 |
05/31/2017 | IRONWOOD PHARMACEUTICALS INC | IRWD | Grant | Class A Common Stock | 15.6k | $0.00 | $0 | | 05/31/2017 |
06/02/2016 | Regulus Therapeutics Inc. | RGLS | Grant | Stock Option (Right to Buy) | 36.6k | $6.20 | $227k | | 06/02/2016 |
06/01/2016 | IRONWOOD PHARMACEUTICALS INC | IRWD | Grant | Class A Common Stock | 23.7k | $0.00 | $0 | | 06/01/2016 |
06/19/2015 | BIOGEN INC. | BIIB | Sale | Common Stock | 3.8k | $410.00 | $1.6M | | 06/19/2015 |
06/10/2015 | Regulus Therapeutics Inc. | RGLS | Grant | Stock Option (Right to Buy) | 17.5k | $10.02 | $175.4k | | 06/10/2015 |
06/03/2015 | IRONWOOD PHARMACEUTICALS INC | IRWD | Grant | Class A Common Stock | 16.6k | $0.00 | $0 | | 06/03/2015 |
02/23/2015 | BIOGEN INC. | BIIB | Grant | Restricted Stock Unit | 8.3k | $0.00 | $0 | | 02/23/2015 |
02/12/2015 | BIOGEN INC. | BIIB | Payment of Exercise | Common Stock | 1.7k | $392.11 | $659.9k | | 02/12/2015 |
02/12/2015 | BIOGEN INC. | BIIB | Exercise | Restricted Stock Unit | 3.6k | $0.00 | $0 | | 02/12/2015 |
02/12/2015 | BIOGEN INC. | BIIB | Payment of Exercise | Common Stock | 767 | $392.11 | $300.7k | | 02/12/2015 |
02/12/2015 | BIOGEN INC. | BIIB | Exercise | Restricted Stock Unit | 1.6k | $0.00 | $0 | | 02/12/2015 |
02/12/2015 | BIOGEN INC. | BIIB | Other (disposition) | Restricted Stock Unit | 1k | $0.00 | $0 | | 02/12/2015 |
02/08/2015 | BIOGEN INC. | BIIB | Payment of Exercise | Common Stock | 1.6k | $402.00 | $656.9k | | 02/08/2015 |
02/08/2015 | BIOGEN INC. | BIIB | Exercise | Restricted Stock Unit | 3.5k | $0.00 | $0 | | 02/08/2015 |
02/01/2015 | BIOGEN INC. | BIIB | Payment of Exercise | Common Stock | 2.1k | $389.16 | $801.3k | | 02/01/2015 |
02/01/2015 | BIOGEN INC. | BIIB | Exercise | Restricted Stock Unit | 5.2k | $0.00 | $0 | | 02/01/2015 |
|